Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00574366 · ClinicalTrials.gov registry record · Phase 1

Erlotinib and Everolimus in Treating Patients With Metastatic Breast Cancer

A Phase 1 study of Breast Cancer, sponsored by Vanderbilt-Ingram Cancer Center.

Completed
Registry status
Phase 1
Development phase
14
Enrollment target
3
Study locations

NCT00574366 is a Phase 1 study of Breast Cancer that has completed, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 14 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (100% lower). The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00574366, a Phase 1 study of Breast Cancer, has completed, sponsored by Vanderbilt-Ingram Cancer Center.

COMPLETED
Registry status
Phase 1
Development phase
14 participants
Enrollment target
3
Study locations

Study Summary

RATIONALE: Erlotinib and everolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving erlotinib together with everolimus may kill more tumor cells. PURPOSE: This phase I/II trial is studying the side effects and best dose of giving erlotinib together with everolimus and to see how well it works in treating patients with metastatic breast cancer.

Conditions Studied

Breast Cancer

Interventions

  • DRUG RAD001
  • DRUG erlotinib

Study Locations (3)

Tennessee

  • Vanderbilt-Ingram Cancer Center - Cool Springs - Nashville
  • Vanderbilt-Ingram Cancer Center at Franklin - Nashville
  • Vanderbilt-Ingram Cancer Center - Nashville

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2005-12
Est. Completion 2009-02
Phase Phase 1

Sponsor

Vanderbilt-Ingram Cancer Center

189 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00574366

The ClinicalTrials.gov registry entry for NCT00574366 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (100% lower). The listed sponsor is Vanderbilt-Ingram Cancer Center, which has 189 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which RAD001 is the first listed.

NCT00574366 reports 3 study locations spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT00574366 about?

NCT00574366 is a clinical study titled "Erlotinib and Everolimus in Treating Patients With Metastatic Breast Cancer". RATIONALE: Erlotinib and everolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving erlotinib together with everolimus may kill more tumor cells. PURPOSE: This phase I/II trial is studying the side effects and best dose of giving erlotinib together ...

What is the current status of trial NCT00574366?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2005-12. Estimated completion is 2009-02.

What conditions does trial NCT00574366 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT00574366?

The interventions under investigation include: RAD001 (DRUG), erlotinib (DRUG).

Who is sponsoring clinical trial NCT00574366?

This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00574366 being conducted?

This trial has 3 study locations across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Breast Cancer

All registered trials for this condition

Tennessee

All trials with a study site in Tennessee

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.